entertainment -WSS

entertainment

author：focus 2025-10-02 00:18:35 - browse：7

The ability of cancer cells to move and spread depends on actin-rich core structures such as the podosomes (yellow) shown here in melanoma cells. Cell nuclei (blue), actin (red), and an actin regulator (green) are also shown. — Metastatic melanoma cells Julio C. Valencia,/NCI Center for Cancer Research

Nearly four decades after its first conception, the first TIL therapy, an immunotherapy that harvests cancer-fighting immune cells from the patient’s own body, received accelerated approval from the Food and Drug Administration for advanced melanoma. The therapy, called Amtagvi or lifileucel from Iovance, is the first cell therapy approved for a solid tumor.

“It’s so exciting and gratifying,” said Allison Betof Warner, a cell therapy researcher and physician at Stanford University who has worked on Amtagvi. “This is a game-changing moment for our field. We’ve seen huge success of cellular therapy for hematologic malignancies, and we’ve yet to capitalize on that for solid tumors. This is hopefully the first of many to come.”

In a Phase 2 clinical trial, titled C-144-01, 153 patients who had already been on a median of three prior lines of therapy received lifileucel, and 31% of them responded to therapy. “These are in very late line patients. They’ve exhausted every standard care option,” Betof Warner said. “The most promising part of this therapy for me is that 42% of patients who responded were still responding for 18 months or longer. It’s truly incredible.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： The Readout: Amylyx, Alumis, and Lundbeck drug updates

focus

WSS

Threats against the LGBTQIA+ community intensifying: Department of Homeland Security

How the political right came to back psychedelics to treat trauma

DOJ reversal could clear way for Carroll's 1st lawsuit against Trump to proceed

HCA discloses massive data breach affecting 11 million patients

In his State of the Union, Biden takes clear aim at 'Big Pharma'

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

knowledge

entertainment

hotspot

Malaria cases in Florida and Texas: Here’s what you need to know

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

Anesthesiologist group: stop taking Ozempic before surgery

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

The high cost of giving birth even with insurance

CDC marks new Covid

In age of alternative facts, a scholarly course on calling out crap

Living with Fabry disease, a condition that causes chronic pain

Wildfire smoke exposes gaps in outdoor worker protections

How the political right came to back psychedelics to treat trauma

focus

Dozens of Pride flags vandalized at Stonewall monument in NYC, 3rd time this month: Police

Study: Pain burden is higher in Black NFL players than white ones

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

Study: Pain burden is higher in Black NFL players than white ones

The drug industry has found itself all alone in Washington

hotspot

focus

Wikipedia

focus